share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4:持股变动声明-董事 Elsbree David B
美股SEC公告 ·  09/17 17:05

Moomoo AI 已提取核心信息

David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David b Elsbree与T2 Biosystems,Inc. [TTOO]相关,于2024年09月13日完成了对55股普通股的卖出交易。交易价格为每股2.42美元,总卖出价值为133.1美元。在此次卖出交易后,Elsbree在该公司的直接持股减少到23股。此外,通过Elsbree的配偶还间接持有2股。
David b Elsbree与T2 Biosystems,Inc. [TTOO]相关,于2024年09月13日完成了对55股普通股的卖出交易。交易价格为每股2.42美元,总卖出价值为133.1美元。在此次卖出交易后,Elsbree在该公司的直接持股减少到23股。此外,通过Elsbree的配偶还间接持有2股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息